Pricing Log in Create free account

Aldeyra Therapeutics, Inc. (ALDX) vs INmune Bio, Inc. (INMB)

Aldeyra Therapeutics, Inc. and INmune Bio, Inc. are both Biotechnology companies. Aldeyra Therapeutics, Inc. and INmune Bio, Inc. are of similar size ($45.8M and $44.5M). Across the 10 metrics below, Aldeyra Therapeutics, Inc. leads on 6 and INmune Bio, Inc. on 4.

Valuation

Metric ALDX INMB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 310.73 9.71
P/B 1.11 2.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 210.43 9.21
Earnings yield (55.71%) (42.68%) (33.15%)
Free cash flow yield (52.20%) (39.17%) (25.50%)

Profitability

Metric ALDX INMB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.48%) (74.82%) (56.36%)
Return on assets (34.80%) (57.08%) (48.04%)
Return on invested capital 0.00% (646.94%) 0.00%

Growth

Metric ALDX INMB Biotechnology median
Revenue growth (TTM) — (51.61%) 6.02%
EPS growth (last fiscal year) 40.43% 11.85% 30.26%
Revenue growth, 5-year CAGR — 35.37% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALDX INMB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.91 4.04 4.72
Net debt to EBITDA 1.52 0.52 0.96

Dividend

Metric ALDX INMB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALDX INMB Biotechnology median
Market cap 44.48m 45.80m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack